Loading...
A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening
BACKGROUND: Prostate-specific antigen (PSA) has modest specificity for prostate cancer. A panel of four kallikrein markers (total, free, and intact PSA and kallikrein-related peptidase 2) is a highly accurate predictor of biopsy outcome. The clinical significance of biopsy-detectable cancers in men...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3035761/ https://ncbi.nlm.nih.gov/pubmed/21148123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-10-1003 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|